nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—malignant glioma	0.462	0.588	CbGaD
Pseudoephedrine—SLC6A3—malignant glioma	0.168	0.214	CbGaD
Pseudoephedrine—TNF—malignant glioma	0.156	0.198	CbGaD
Pseudoephedrine—IL2—blood vessel—malignant glioma	0.00631	0.156	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalic ventricle—malignant glioma	0.00337	0.0833	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—malignant glioma	0.0019	0.0471	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—malignant glioma	0.00186	0.046	CbGeAlD
Pseudoephedrine—IL2—central nervous system—malignant glioma	0.00174	0.043	CbGeAlD
Pseudoephedrine—NFATC1—brain—malignant glioma	0.00151	0.0374	CbGeAlD
Pseudoephedrine—IL2—brain—malignant glioma	0.00138	0.0342	CbGeAlD
Pseudoephedrine—SLC6A3—brainstem—malignant glioma	0.000911	0.0225	CbGeAlD
Pseudoephedrine—SLC6A4—brainstem—malignant glioma	0.000835	0.0207	CbGeAlD
Pseudoephedrine—SLC6A3—telencephalon—malignant glioma	0.000808	0.02	CbGeAlD
Pseudoephedrine—ADRB1—telencephalon—malignant glioma	0.000767	0.019	CbGeAlD
Pseudoephedrine—SLC6A4—telencephalon—malignant glioma	0.000741	0.0183	CbGeAlD
Pseudoephedrine—MAOA—embryo—malignant glioma	0.000739	0.0183	CbGeAlD
Pseudoephedrine—SLC6A2—brainstem—malignant glioma	0.000735	0.0182	CbGeAlD
Pseudoephedrine—ADRA1A—brainstem—malignant glioma	0.000683	0.0169	CbGeAlD
Pseudoephedrine—MAOA—brainstem—malignant glioma	0.000677	0.0168	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Carmustine—malignant glioma	0.000661	0.0889	CcSEcCtD
Pseudoephedrine—MAOA—retina—malignant glioma	0.000653	0.0162	CbGeAlD
Pseudoephedrine—SLC6A2—telencephalon—malignant glioma	0.000652	0.0161	CbGeAlD
Pseudoephedrine—Cerebral haemorrhage—Temozolomide—malignant glioma	0.000639	0.0859	CcSEcCtD
Pseudoephedrine—ADRA1A—telencephalon—malignant glioma	0.000606	0.015	CbGeAlD
Pseudoephedrine—MAOA—telencephalon—malignant glioma	0.000601	0.0149	CbGeAlD
Pseudoephedrine—SLC6A3—midbrain—malignant glioma	0.00058	0.0144	CbGeAlD
Pseudoephedrine—SLC6A3—spinal cord—malignant glioma	0.000566	0.014	CbGeAlD
Pseudoephedrine—Paranoia—Carmustine—malignant glioma	0.000537	0.0722	CcSEcCtD
Pseudoephedrine—SLC6A4—midbrain—malignant glioma	0.000532	0.0132	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—malignant glioma	0.000519	0.0128	CbGeAlD
Pseudoephedrine—SLC6A2—medulla oblongata—malignant glioma	0.000512	0.0127	CbGeAlD
Pseudoephedrine—MAOA—medulla oblongata—malignant glioma	0.000472	0.0117	CbGeAlD
Pseudoephedrine—ADRA2A—telencephalon—malignant glioma	0.000461	0.0114	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—malignant glioma	0.000459	0.0114	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—malignant glioma	0.000449	0.0111	CbGeAlD
Pseudoephedrine—Ephedrine—BCHE—malignant glioma	0.000446	0.138	CrCbGaD
Pseudoephedrine—ADRB1—central nervous system—malignant glioma	0.000436	0.0108	CbGeAlD
Pseudoephedrine—MAOA—midbrain—malignant glioma	0.000431	0.0107	CbGeAlD
Pseudoephedrine—Benzyl alcohol—CYP2B6—malignant glioma	0.000421	0.13	CrCbGaD
Pseudoephedrine—SLC6A4—central nervous system—malignant glioma	0.000421	0.0104	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—malignant glioma	0.000421	0.0104	CbGeAlD
Pseudoephedrine—Phenylpropanolamine—SLC6A3—malignant glioma	0.000417	0.129	CrCbGaD
Pseudoephedrine—Selegiline—CYP2B6—malignant glioma	0.000404	0.125	CrCbGaD
Pseudoephedrine—CYP2D6—brainstem—malignant glioma	0.000402	0.00996	CbGeAlD
Pseudoephedrine—Phentermine—SLC6A3—malignant glioma	0.000372	0.115	CrCbGaD
Pseudoephedrine—SLC6A2—central nervous system—malignant glioma	0.000371	0.00917	CbGeAlD
Pseudoephedrine—SLC6A3—brain—malignant glioma	0.000365	0.00903	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—malignant glioma	0.000362	0.00896	CbGeAlD
Pseudoephedrine—CYP2D6—telencephalon—malignant glioma	0.000357	0.00884	CbGeAlD
Pseudoephedrine—Dextroamphetamine—SLC6A3—malignant glioma	0.000355	0.11	CrCbGaD
Pseudoephedrine—ADRB1—brain—malignant glioma	0.000346	0.00856	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—malignant glioma	0.000345	0.00853	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—malignant glioma	0.000341	0.00845	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—malignant glioma	0.000337	0.00834	CbGeAlD
Pseudoephedrine—SLC6A4—brain—malignant glioma	0.000334	0.00827	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—malignant glioma	0.000334	0.00826	CbGeAlD
Pseudoephedrine—ADRA2A—midbrain—malignant glioma	0.000331	0.00819	CbGeAlD
Pseudoephedrine—ADRA2A—spinal cord—malignant glioma	0.000323	0.00799	CbGeAlD
Pseudoephedrine—SLC6A2—brain—malignant glioma	0.000294	0.00728	CbGeAlD
Pseudoephedrine—Amphetamine—SLC6A3—malignant glioma	0.000286	0.0887	CrCbGaD
Pseudoephedrine—ADRA1A—brain—malignant glioma	0.000274	0.00677	CbGeAlD
Pseudoephedrine—MAOA—brain—malignant glioma	0.000271	0.00671	CbGeAlD
Pseudoephedrine—Methamphetamine—SLC6A3—malignant glioma	0.000265	0.0822	CrCbGaD
Pseudoephedrine—ADRA2A—central nervous system—malignant glioma	0.000262	0.00649	CbGeAlD
Pseudoephedrine—Atomoxetine—SLC6A3—malignant glioma	0.000261	0.0808	CrCbGaD
Pseudoephedrine—ADRA2A—cerebellum—malignant glioma	0.000256	0.00634	CbGeAlD
Pseudoephedrine—ADRA2A—brain—malignant glioma	0.000208	0.00515	CbGeAlD
Pseudoephedrine—Dysuria—Temozolomide—malignant glioma	0.000207	0.0279	CcSEcCtD
Pseudoephedrine—CYP2D6—central nervous system—malignant glioma	0.000203	0.00502	CbGeAlD
Pseudoephedrine—CYP2D6—cerebellum—malignant glioma	0.000198	0.00491	CbGeAlD
Pseudoephedrine—Hallucination—Carmustine—malignant glioma	0.000183	0.0246	CcSEcCtD
Pseudoephedrine—Hallucination—Temozolomide—malignant glioma	0.000177	0.0238	CcSEcCtD
Pseudoephedrine—Arrhythmia—Carmustine—malignant glioma	0.000164	0.0221	CcSEcCtD
Pseudoephedrine—CYP2D6—brain—malignant glioma	0.000161	0.00399	CbGeAlD
Pseudoephedrine—Tremor—Carmustine—malignant glioma	0.00015	0.0201	CcSEcCtD
Pseudoephedrine—Agitation—Carmustine—malignant glioma	0.000147	0.0198	CcSEcCtD
Pseudoephedrine—Tremor—Temozolomide—malignant glioma	0.000145	0.0195	CcSEcCtD
Pseudoephedrine—Agitation—Temozolomide—malignant glioma	0.000142	0.0191	CcSEcCtD
Pseudoephedrine—Vertigo—Temozolomide—malignant glioma	0.000139	0.0187	CcSEcCtD
Pseudoephedrine—Hypertension—Carmustine—malignant glioma	0.000138	0.0186	CcSEcCtD
Pseudoephedrine—Palpitations—Temozolomide—malignant glioma	0.000137	0.0184	CcSEcCtD
Pseudoephedrine—Chest pain—Carmustine—malignant glioma	0.000136	0.0183	CcSEcCtD
Pseudoephedrine—Anxiety—Carmustine—malignant glioma	0.000136	0.0182	CcSEcCtD
Pseudoephedrine—Hypertension—Temozolomide—malignant glioma	0.000133	0.0179	CcSEcCtD
Pseudoephedrine—Confusional state—Carmustine—malignant glioma	0.000132	0.0177	CcSEcCtD
Pseudoephedrine—Anxiety—Temozolomide—malignant glioma	0.000131	0.0176	CcSEcCtD
Pseudoephedrine—Tachycardia—Carmustine—malignant glioma	0.000127	0.0171	CcSEcCtD
Pseudoephedrine—Confusional state—Temozolomide—malignant glioma	0.000127	0.0171	CcSEcCtD
Pseudoephedrine—Anorexia—Carmustine—malignant glioma	0.000124	0.0167	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Temozolomide—malignant glioma	0.000122	0.0164	CcSEcCtD
Pseudoephedrine—Anorexia—Temozolomide—malignant glioma	0.00012	0.0162	CcSEcCtD
Pseudoephedrine—Insomnia—Carmustine—malignant glioma	0.000118	0.0159	CcSEcCtD
Pseudoephedrine—Dyspnoea—Carmustine—malignant glioma	0.000116	0.0156	CcSEcCtD
Pseudoephedrine—Insomnia—Temozolomide—malignant glioma	0.000114	0.0153	CcSEcCtD
Pseudoephedrine—Decreased appetite—Carmustine—malignant glioma	0.000113	0.0153	CcSEcCtD
Pseudoephedrine—Dyspnoea—Temozolomide—malignant glioma	0.000112	0.0151	CcSEcCtD
Pseudoephedrine—Pain—Carmustine—malignant glioma	0.000112	0.015	CcSEcCtD
Pseudoephedrine—Dyspepsia—Temozolomide—malignant glioma	0.000111	0.0149	CcSEcCtD
Pseudoephedrine—Decreased appetite—Temozolomide—malignant glioma	0.00011	0.0147	CcSEcCtD
Pseudoephedrine—Pain—Temozolomide—malignant glioma	0.000108	0.0145	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Carmustine—malignant glioma	0.000108	0.0145	CcSEcCtD
Pseudoephedrine—Feeling abnormal—Temozolomide—malignant glioma	0.000104	0.014	CcSEcCtD
Pseudoephedrine—Body temperature increased—Carmustine—malignant glioma	0.000103	0.0139	CcSEcCtD
Pseudoephedrine—Body temperature increased—Temozolomide—malignant glioma	9.97e-05	0.0134	CcSEcCtD
Pseudoephedrine—Asthenia—Carmustine—malignant glioma	9.36e-05	0.0126	CcSEcCtD
Pseudoephedrine—Asthenia—Temozolomide—malignant glioma	9.05e-05	0.0122	CcSEcCtD
Pseudoephedrine—Dizziness—Carmustine—malignant glioma	8.63e-05	0.0116	CcSEcCtD
Pseudoephedrine—Dizziness—Temozolomide—malignant glioma	8.34e-05	0.0112	CcSEcCtD
Pseudoephedrine—Vomiting—Carmustine—malignant glioma	8.3e-05	0.0112	CcSEcCtD
Pseudoephedrine—Rash—Carmustine—malignant glioma	8.23e-05	0.0111	CcSEcCtD
Pseudoephedrine—Dermatitis—Carmustine—malignant glioma	8.22e-05	0.0111	CcSEcCtD
Pseudoephedrine—Headache—Carmustine—malignant glioma	8.18e-05	0.011	CcSEcCtD
Pseudoephedrine—Vomiting—Temozolomide—malignant glioma	8.02e-05	0.0108	CcSEcCtD
Pseudoephedrine—Rash—Temozolomide—malignant glioma	7.95e-05	0.0107	CcSEcCtD
Pseudoephedrine—Dermatitis—Temozolomide—malignant glioma	7.94e-05	0.0107	CcSEcCtD
Pseudoephedrine—Headache—Temozolomide—malignant glioma	7.9e-05	0.0106	CcSEcCtD
Pseudoephedrine—Nausea—Carmustine—malignant glioma	7.75e-05	0.0104	CcSEcCtD
Pseudoephedrine—Nausea—Temozolomide—malignant glioma	7.49e-05	0.0101	CcSEcCtD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFRA—malignant glioma	6.21e-06	3.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	6.17e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SPP1—malignant glioma	6.17e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PTPN11—malignant glioma	6.16e-06	3.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	6.14e-06	3.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—CXCL8—malignant glioma	6.14e-06	3.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH2—malignant glioma	6.12e-06	3.73e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTT1—malignant glioma	6.1e-06	3.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CD—malignant glioma	6.07e-06	3.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SPP1—malignant glioma	6.03e-06	3.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—CXCL8—malignant glioma	6e-06	3.66e-05	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKT1—malignant glioma	5.99e-06	3.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KNG1—malignant glioma	5.99e-06	3.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NCOR1—malignant glioma	5.96e-06	3.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	5.93e-06	3.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL2—malignant glioma	5.87e-06	3.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TERT—malignant glioma	5.85e-06	3.57e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CD—malignant glioma	5.83e-06	3.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL2—malignant glioma	5.74e-06	3.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT2—malignant glioma	5.73e-06	3.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TERT—malignant glioma	5.72e-06	3.49e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS1—malignant glioma	5.72e-06	3.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP3—malignant glioma	5.71e-06	3.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PDGFB—malignant glioma	5.71e-06	3.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NTRK1—malignant glioma	5.7e-06	3.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	5.69e-06	3.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGFR1—malignant glioma	5.68e-06	3.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	5.66e-06	3.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HIF1A—malignant glioma	5.59e-06	3.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PDGFB—malignant glioma	5.58e-06	3.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—KRAS—malignant glioma	5.55e-06	3.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGFR1—malignant glioma	5.55e-06	3.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	5.51e-06	3.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTK2—malignant glioma	5.49e-06	3.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	5.47e-06	3.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HIF1A—malignant glioma	5.47e-06	3.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CAV1—malignant glioma	5.41e-06	3.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES1—malignant glioma	5.4e-06	3.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	5.37e-06	3.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KDR—malignant glioma	5.35e-06	3.26e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—BCHE—malignant glioma	5.31e-06	3.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP3—malignant glioma	5.3e-06	3.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	5.29e-06	3.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CAV1—malignant glioma	5.29e-06	3.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	5.29e-06	3.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	5.26e-06	3.21e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SLC5A5—malignant glioma	5.25e-06	3.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KDR—malignant glioma	5.23e-06	3.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	5.23e-06	3.19e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	5.17e-06	3.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—F2—malignant glioma	5.15e-06	3.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FN1—malignant glioma	5.15e-06	3.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	5.14e-06	3.13e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTK2—malignant glioma	5.1e-06	3.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PIK3CA—malignant glioma	5.1e-06	3.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BAD—malignant glioma	5.08e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	5.08e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CB—malignant glioma	5.08e-06	3.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH1—malignant glioma	5.04e-06	3.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—F2—malignant glioma	5.03e-06	3.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FN1—malignant glioma	5.03e-06	3.07e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—malignant glioma	5.03e-06	3.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES1—malignant glioma	5.01e-06	3.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SPP1—malignant glioma	4.99e-06	3.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	4.99e-06	3.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BAD—malignant glioma	4.97e-06	3.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	4.97e-06	3.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—malignant glioma	4.93e-06	3.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CD80—malignant glioma	4.93e-06	3.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH1—malignant glioma	4.93e-06	3.01e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APC—malignant glioma	4.92e-06	3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CG—malignant glioma	4.92e-06	3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	4.92e-06	3e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGF—malignant glioma	4.87e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CAV1—malignant glioma	4.86e-06	2.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	4.86e-06	2.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTPN11—malignant glioma	4.84e-06	2.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CD80—malignant glioma	4.83e-06	2.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APC—malignant glioma	4.82e-06	2.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CG—malignant glioma	4.82e-06	2.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	4.8e-06	2.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	4.77e-06	2.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGF—malignant glioma	4.76e-06	2.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL2—malignant glioma	4.75e-06	2.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTPN11—malignant glioma	4.73e-06	2.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TERT—malignant glioma	4.73e-06	2.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SPP1—malignant glioma	4.64e-06	2.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BRAF—malignant glioma	4.63e-06	2.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	4.62e-06	2.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	4.61e-06	2.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	4.59e-06	2.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BRAF—malignant glioma	4.53e-06	2.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	4.52e-06	2.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT2—malignant glioma	4.51e-06	2.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—malignant glioma	4.49e-06	2.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CG—malignant glioma	4.43e-06	2.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL2—malignant glioma	4.41e-06	2.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT2—malignant glioma	4.41e-06	2.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TERT—malignant glioma	4.39e-06	2.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—malignant glioma	4.39e-06	2.68e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTEN—malignant glioma	4.39e-06	2.68e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CAV1—malignant glioma	4.37e-06	2.67e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CD—malignant glioma	4.33e-06	2.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KDR—malignant glioma	4.33e-06	2.64e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	4.29e-06	2.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—PIK3CA—malignant glioma	4.29e-06	2.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PPARG—malignant glioma	4.27e-06	2.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	4.27e-06	2.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—KRAS—malignant glioma	4.24e-06	2.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CD—malignant glioma	4.23e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—malignant glioma	4.23e-06	2.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	4.2e-06	2.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—PIK3CA—malignant glioma	4.19e-06	2.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—AKT1—malignant glioma	4.17e-06	2.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—F2—malignant glioma	4.16e-06	2.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FN1—malignant glioma	4.16e-06	2.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—KRAS—malignant glioma	4.15e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGF2—malignant glioma	4.15e-06	2.53e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAT—malignant glioma	4.11e-06	2.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BAD—malignant glioma	4.11e-06	2.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	4.07e-06	2.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CAV1—malignant glioma	4.06e-06	2.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGF2—malignant glioma	4.05e-06	2.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KDR—malignant glioma	4.02e-06	2.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CD80—malignant glioma	3.99e-06	2.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	3.98e-06	2.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APC—malignant glioma	3.98e-06	2.43e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGF—malignant glioma	3.94e-06	2.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	3.91e-06	2.39e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PIK3CA—malignant glioma	3.89e-06	2.38e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CD—malignant glioma	3.89e-06	2.37e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NCOR1—malignant glioma	3.89e-06	2.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—malignant glioma	3.88e-06	2.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—F2—malignant glioma	3.87e-06	2.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FN1—malignant glioma	3.87e-06	2.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RAF1—malignant glioma	3.87e-06	2.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB2—malignant glioma	3.82e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BAD—malignant glioma	3.82e-06	2.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PIK3CA—malignant glioma	3.81e-06	2.32e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—malignant glioma	3.79e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	3.79e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RAF1—malignant glioma	3.78e-06	2.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CB—malignant glioma	3.77e-06	2.3e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	3.75e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB2—malignant glioma	3.74e-06	2.28e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CD80—malignant glioma	3.71e-06	2.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	3.7e-06	2.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APC—malignant glioma	3.7e-06	2.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CB—malignant glioma	3.69e-06	2.25e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGF—malignant glioma	3.66e-06	2.23e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	3.65e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	3.64e-06	2.22e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	3.63e-06	2.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CXCL8—malignant glioma	3.63e-06	2.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CXCL8—malignant glioma	3.55e-06	2.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKT1—malignant glioma	3.5e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	3.5e-06	2.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BRAF—malignant glioma	3.48e-06	2.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—malignant glioma	3.47e-06	2.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	3.47e-06	2.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL2—malignant glioma	3.47e-06	2.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	3.43e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKT1—malignant glioma	3.43e-06	2.09e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—malignant glioma	3.4e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CB—malignant glioma	3.39e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL2—malignant glioma	3.39e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT2—malignant glioma	3.39e-06	2.07e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	3.37e-06	2.06e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—malignant glioma	3.36e-06	2.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	3.35e-06	2.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—malignant glioma	3.28e-06	2e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PTEN—malignant glioma	3.26e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	3.25e-06	1.99e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	3.22e-06	1.97e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—malignant glioma	3.21e-06	1.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PTEN—malignant glioma	3.19e-06	1.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	3.19e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKT1—malignant glioma	3.18e-06	1.94e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CAV1—malignant glioma	3.17e-06	1.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	3.15e-06	1.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	3.14e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	3.13e-06	1.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGF2—malignant glioma	3.12e-06	1.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKT1—malignant glioma	3.11e-06	1.9e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PIK3CA—malignant glioma	3.1e-06	1.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	3.09e-06	1.89e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	3.05e-06	1.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—malignant glioma	2.95e-06	1.8e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	2.93e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTEN—malignant glioma	2.93e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	2.93e-06	1.79e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—malignant glioma	2.92e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—malignant glioma	2.92e-06	1.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RAF1—malignant glioma	2.91e-06	1.77e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CG—malignant glioma	2.89e-06	1.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—malignant glioma	2.88e-06	1.76e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	2.87e-06	1.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—malignant glioma	2.85e-06	1.74e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	2.84e-06	1.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	2.83e-06	1.73e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	2.81e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL2—malignant glioma	2.8e-06	1.71e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PPARG—malignant glioma	2.78e-06	1.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	2.73e-06	1.66e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MYC—malignant glioma	2.71e-06	1.65e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	2.65e-06	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MYC—malignant glioma	2.65e-06	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—malignant glioma	2.65e-06	1.62e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	2.64e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	2.63e-06	1.61e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—malignant glioma	2.61e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL2—malignant glioma	2.61e-06	1.59e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—malignant glioma	2.59e-06	1.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	2.57e-06	1.57e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CD—malignant glioma	2.54e-06	1.55e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—AKT1—malignant glioma	2.53e-06	1.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KRAS—malignant glioma	2.5e-06	1.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—malignant glioma	2.47e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PTEN—malignant glioma	2.45e-06	1.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KRAS—malignant glioma	2.45e-06	1.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	2.39e-06	1.46e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	2.38e-06	1.45e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	2.36e-06	1.44e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PIK3CA—malignant glioma	2.3e-06	1.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PIK3CA—malignant glioma	2.25e-06	1.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—malignant glioma	2.23e-06	1.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	2.21e-06	1.35e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.21e-06	1.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MYC—malignant glioma	2.19e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—malignant glioma	2.19e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—malignant glioma	2.19e-06	1.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—malignant glioma	2.18e-06	1.33e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	2.14e-06	1.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PIK3CA—malignant glioma	2.07e-06	1.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MYC—malignant glioma	2.04e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	2.03e-06	1.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.99e-06	1.22e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTEN—malignant glioma	1.91e-06	1.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.88e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKT1—malignant glioma	1.88e-06	1.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.86e-06	1.14e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKT1—malignant glioma	1.84e-06	1.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.8e-06	1.1e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.73e-06	1.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—AKT1—malignant glioma	1.69e-06	1.03e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.67e-06	1.02e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.52e-06	9.28e-06	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKT1—malignant glioma	1.41e-06	8.62e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.35e-06	8.22e-06	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—AKT1—malignant glioma	1.1e-06	6.72e-06	CbGpPWpGaD
